Is there a role of magnetic resonance imaging in deciding to stop anti-tumor necrosis factor treatment in ileal Crohn's disease?

被引：5
|
作者：
Gallego, Jose C. [1 ]
Echarri, Ana [2 ]
机构：
[1] Complexo Hosp Univ Ferrol, Radiol Dept, Av Residencia S-N, Ferrol 15405, Spain
[2] Complexo Hosp Univ Ferrol, Gastroenterol Dept, Ferrol, Spain
来源：
CLINICAL IMAGING | 2017年 / 43卷
关键词：
Crohn's disease; Magnetic resonance imaging; Anti-tumor necrosis factor agents; INFLAMMATORY-BOWEL-DISEASE; INFLIXIMAB THERAPY; CLINICAL REMISSION; FOLLOW-UP; DISCONTINUATION; MAINTENANCE; RELAPSE;
D O I：
10.1016/j.clinimag.2017.03.010
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Purpose: This study was performed to assess the ability of magnetic resonance enterography to predict the evolution of patients in whom anti-tumor necrosis factor-alpha therapy was suspended. Methods: A prospective study of patients with ileal Crohn's disease was performed. Results: Twenty-nine patients were included. Patients who later relapsed showed higher magnetic resonance scores than those who did not relapse (4.2 vs. 2.5, respectively; p < 0.02). The area under the receiving-operating characteristics curve was 0.755 when discriminating patients who relapsed. Conclusions: Magnetic resonance enterography should be taken into account when deciding the withdrawal of anti-tumor necrosis factor-alpha in patients with Crohn's disease. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码：175 / 179
页数：5
相关论文
共 50 条
  • [21] Real world dosing of anti-tumor necrosis factor therapies in the treatment of adults with Crohn's disease
    Waters, H.
    Meekins, T.
    Bewtra, A.
    McKenzie, R.
    Tang, B.
    Piech, C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S393 - S393
  • [22] Real world dosing of anti-tumor Necrosis factor therapies in the treatment of adults with Crohn's Disease
    Waters, H.
    Meekins, T.
    Bewtra, A.
    McKenzie, R.
    Tang, B.
    Piech, C.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S4 - S4
  • [23] Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Patil, Seema A.
    Flasar, Mark H.
    Lin, Jay
    Lingohr-Smith, Melissa
    Skup, Martha
    Wang, Song
    Chao, Jingdong
    Cross, Raymond K.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (01) : 60 - 67
  • [24] Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn’s Disease
    Seema A. Patil
    Mark H. Flasar
    Jay Lin
    Melissa Lingohr-Smith
    Martha Skup
    Song Wang
    Jingdong Chao
    Raymond K. Cross
    Digestive Diseases and Sciences, 2019, 64 : 60 - 67
  • [25] Demyelination during anti-tumor necrosis factor α therapy with infliximab for Crohn's disease
    Thomas, CW
    Weinshenker, BG
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (01) : 28 - 31
  • [26] Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab
    Korzenik, JR
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 285 - +
  • [27] Functional modulation of crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies
    Di Sabatino, Antonio
    Pender, Sylvia L. F.
    Jackson, Claire L.
    Prothero, Joanna D.
    Gordon, John N.
    Picariello, Lucia
    Rovedatti, Laura
    Docena, Guillermo
    Monteleone, Giovanni
    Rampton, David S.
    Tonelli, Francesco
    Corazza, Gino R.
    Macdonald, Thomas T.
    GASTROENTEROLOGY, 2007, 133 (01) : 137 - 149
  • [28] Effectiveness and Safety of lmmunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen M.
    Chen, Lang
    Xie, Fenglong
    Curtis, Jeffrey R.
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1293 - +
  • [29] Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease
    Nguyen, Douglas L.
    Flores, Sarah
    Sassi, Kareem
    Bechtold, Matthew L.
    Nguyen, Emily T.
    Parekh, Nimisha K.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 147 - 154
  • [30] Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease
    Laurie S. Conklin
    Bernard Cohen
    Lindsay Wilson
    Carmen Cuffari
    Maria Oliva-Hemker
    Nature Reviews Gastroenterology & Hepatology, 2010, 7 : 174 - 177
12345